Elite Pharmaceuticals, a specialty pharmaceutical company developing a pipeline of abuse-deterrent opioids and niche generic products, today reported new appointments to key management positions. Dr. Kennedy Smith, J.D., M.B.A. joins Elite as Vice President of Legal; Dr. Jason LePree as Vice President of Scientific Affairs; and Dr. Sophy Abraham as Vice President of Regulatory Affairs.
“We are pleased to welcome Ken, Jason, and Sophy to the Elite team and I’m thrilled with the caliber of expertise that these individuals bring to Elite,” said Nasrat Hakim, Elite’s President and Chief Executive Officer. “These additions greatly strengthen our management team in key areas and enhance our internal expertise in product development, regulatory compliance, and intellectual property to support the development of our opioid abuse deterrent products.”
Prior to his new role at Elite, Dr. Smith served as Chief Intellectual Property Counsel for Alpharma Incorporated. Before that, he was Head of North American Intellectual Property for Sanofi Aventis. In both roles, Dr. Smith held global responsibilities for intellectual property pertaining to multiple business units involved with many technologies. These included branded products, animal health products, active pharmaceutical ingredients, generic drugs, and vaccines. He also has a strong background in abuse deterrent intellectual property. Dr. Smith holds a Ph.D. in Biochemistry from University of Houston, an M.B.A from Lehigh University, and a J.D. from the University of Houston.
For his new role at Elite, Dr. LePree brings a wealth of experience in formulations, analytical research, and development. His previous position was Principal Scientist, Formulations Research and Development for Capsugel. Dr. LePree also draws upon a background in research and development, as he served in R&D positions at Abon Pharmaceuticals, Penwest Pharmaceuticals, Novartis, and Hoffman-LaRoche. With a B.S. in Pharmacy from Rutgers University and a Ph.D. in Pharmacy from the University of Wisconsin, he is also active in academia as an Adjunct Professor of Pharmacy at Long Island University.
Having worked over 20 years at Teva Pharmaceuticals, Dr. Abraham has significant regulatory and analytical experience. Prior to Elite, she served as Senior Regulatory Associate at Teva. Dr. Abraham holds a B.S. in Zoology, Botany, and Chemistry from the University of Kerala, India and a Ph.D. in Zoology from the University of Baroda, India.
For more information, visit www.elitepharma.com
Let us hear your thoughts below: